Logo image
Superior Treg-Expanding Properties of a Novel Dual-Acting Cytokine Fusion Protein
Journal article   Open access   Peer reviewed

Superior Treg-Expanding Properties of a Novel Dual-Acting Cytokine Fusion Protein

Tanja Padutsch, Maksim Sendetski, Carina Huber, Nathalie Peters, Klaus Pfizenmaier, John R. Bethea, Roland E. Kontermann and Roman Fischer
Frontiers in pharmacology, v 10, pp 1490-1490
18 Dec 2019
PMID: 31920671
url
https://doi.org/10.3389/fphar.2019.01490View
Published, Version of Record (VoR)CC BY V4.0 Open

Abstract

autoimmune disease cytokine fusion proteins genetic engineering IL-2 inflammation Pharmacology TNF TNFR2 Tregs
Autoimmune diseases are caused by uncontrolled endogenous immune responses against healthy cells. They may develop due to an impaired function of regulatory T cells (Tregs), which normally suppress self-specific effector immune cells. Interleukin 2 (IL-2) and tumor necrosis factor (TNF) have been identified as key players that promote expansion, function, and stability of Tregs. In vivo , both low-dose IL-2 therapy and TNF receptor 2 (TNFR2) agonism were shown to expand Tregs and alleviate autoimmunity. We here designed a novel dimeric dual-acting fusion cytokine, where mouse IL-2 is genetically linked to a TNFR2-selective single-chain TNF mutein (IL2-EHD2-sc-mTNF R2 ). IL2-EHD2-sc-mTNF R2 showed high affinity to TNFR2 and efficiently activated IL-2 and TNFR2-selective signaling pathways. Further, IL2-EHD2-sc-mTNF R2 promoted superior Treg expansion, with both the IL-2 and the TNFR2 agonist (sc-mTNF R2 ) component necessary for this biological response. Ultimately, we propose that IL2-EHD2-sc-mTNF R2 is a dual-acting cytokine that efficiently promotes Treg expansion and might have a superior therapeutic window than conventional IL-2-based drugs.

Metrics

7 Record Views
14 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
International collaboration
Web of Science research areas
Pharmacology & Pharmacy
Logo image